Related Experiment Video
Updated: Jun 4, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
["Molecular-targeting prevention" of cancer. The theory and its possibilities]
1Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Japan. tsakai@koto.kpu-m.ac.jp
Abstract:
In previous prevention studies, molecular targets were not intended. We then proposed the concept termed "molecular-targeting prevention" and applied it to cancer prevention. In most malignant tumors, tumor-suppressor genes, the retinoblastoma gene (RB) and/or the p53 gene are considered to be inactivated. We therefore hypothesized that RB and/or p53 might be good candidates for the molecular-targeting prevention of cancer. Interestingly, many cancer-preventive food factors were found to reactivate the lost functions of RB and/or p53 by a "gene-regulating chemoprevention" strategy. We next proposed the concept termed "combination-oriented molecular-targeting prevention", in which only the preventive effects are synergistically enhanced. We then investigated the TNF-related apoptosis-inducing ligand (TRAIL)-death receptor 5 (DR5) pathway as a candidate of the target, and found that many cancer-preventive food factors could enhance the pathway resulting in the synergistic apoptosis of various cancer cells. We hope that these strategies will contribute to the prevention of cancer.
Insights
Molecular-targeting prevention reactivates tumor suppressor genes like retinoblastoma (RB) and p53. Cancer-preventive foods enhance pathways like TRAIL-DR5, synergistically boosting apoptosis and cancer prevention.
Area of Science:
- Oncology
- Molecular Biology
- Preventive Medicine
Context:
- Traditional cancer prevention often lacks specific molecular targets.
- Tumor suppressor genes, such as retinoblastoma (RB) and p53, are frequently inactivated in malignant tumors.
Purpose:
- To introduce and explore the concept of "molecular-targeting prevention" for cancer.
- To investigate the role of RB and p53 genes in cancer prevention strategies.
- To examine the potential of food-derived factors in cancer prevention via gene regulation and apoptosis induction.
Summary:
- Proposed "molecular-targeting prevention" strategy focusing on reactivating inactivated tumor suppressor genes (RB and/or p53).
- Identified that "gene-regulating chemoprevention" using food factors can restore RB/p53 functions.
- Introduced "combination-oriented molecular-targeting prevention" to synergistically enhance preventive effects.
- Investigated the TNF-related apoptosis-inducing ligand (TRAIL)-death receptor 5 (DR5) pathway, finding food factors enhance it for synergistic cancer cell apoptosis.
Impact:
- Suggests novel strategies for cancer prevention by targeting specific molecular pathways.
- Highlights the potential of dietary components in cancer chemoprevention.
- Aims to contribute to more effective cancer prevention through synergistic approaches.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer

